![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Bayer And NextRNA Partner On New Small Molecule Cancer Drugs
Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to...
Strategies To Improve Cell Line Development For Biologics
The capacity of a cell line to create a biologic that is both safe and...
Nuclear Medicine In North America: Market Growth & Trends
The North American nuclear medicine market was estimated to be worth USD 2.05 billion in...
Bayer & NextRNA Partner In $547Million Cancer Therapy Deal
This summer, Bayer officials made sure Fierce understood that the company's desire for deals hasn't...
ST Pharm and Quantoom Partner to Enhance RNA Manufacturing Flexibility
ST Pharm and Quantoom Biosciences have announced an extended collaboration to advance the development and...
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company, announced that it has entered into a joint research...
Novartis and Versant Ventures Launch Borealis Biosciences with $150M Investment
Novartis and Versant Ventures have launched Borealis Biosciences with a substantial $150 million Series A...
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research...
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines,...
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced that it has entered into a Master...